Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Ainos Inc

AIMD ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: N/A

Last Close

$1.42

▼ -1.39%

Market Cap $10.49M · Vol 5.83K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$10.49M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

58.33

Momentum

Beta

1.07

vs Market

52W High

$4.44

68.02% below

52W Low

$1.27

11.81% above

Volume

5.83K

Avg 16.23K

P/B

1.26

Price-to-book

ROE

117.51%

Return on equity

Free Float

28.65%

Public shares

Shariah Compliance8 STANDARDS

✗ Ainos Inc (AIMD) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does AIMD pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.96%

-25.26%

-17.44%

-6.58%

YTD

-13.41%

-62.83%

-91.79%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$124.16K
Net Income	$-14,771,010.00
Revenue Growth (YoY)	-96.74%
Gross Margin	82.89%
Operating Margin	-11,268.32%
Net Profit Margin	-11,897.04%
ROE	117.51%
ROA · ROIC	-59.45% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	56.41
P/B	1.26
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	7.38M

Technical Indicators

50-Day SMA	$1.71
200-Day SMA	$1.88
RSI (14)	58.33
Beta	1.07
52-Week High	$4.44
52-Week Low	$1.27

Volume Today	5.83K
Avg Daily Volume (30D)	16.23K
Relative Volume	0.36x
Volatility (10D)	69.20
Volatility (30D)	71.56
Free Float	28.65%

Analyst Consensus

N/A

Current Price $1.42

Mean Target N/A

52W Low$1.27 52W High$4.44

Current

Target

$1.27 $4.44

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001S965R0

ISINUS00902F4028

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.